8-K 1 v112470_8k.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
May 1, 2008
Date of Report (date of earliest event reported)

BIOFORM MEDICAL, INC.
(Exact name of Registrant as specified in its charter)
 
 
 
 
 
Delaware
 
001-33791
 
39-1979642
(State of incorporation)
 
(Commission File Number)
 
(I.R.S. Employer
Identification Number)

1875 South Grant Street, Suite 110
San Mateo, California 94402
(Address of principal executive offices)

(650) 286-4000
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
Item 2.02.
Results of Operations and Financial Condition.

On May 1, 2008, BioForm Medical, Inc. (“BioForm”) issued a press release announcing financial results for the quarter ended March 31, 2008, which is the Company’s third quarter of fiscal year 2008. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

This information and the information contained in the press release shall not be deemed “filed” for purposes of  Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report is not incorporated by reference into any filings of BioForm made under the Securities Act of 1933, as amended, whether made before or after the date of this Current Report, regardless of any general information language in the filing unless specifically stated so therein.
Item 9.01.
Financial Statements and Exhibits.

(d) Exhibits.
 
 
 
Exhibit No.
 
Description
99.1
 
Press Release of BioForm Medical, Inc. dated as of May 1, 2008.


 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 
 
 
 
 
BioForm Medical, Inc.
 
 
 
 
Date: May 1, 2008
 
 
 
By:
 
/s/ Derek Bertocci
 
 
 
 
 
 
 
 
Derek Bertocci
Chief Financial Officer